Compare XRX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRX | CYRX |
|---|---|---|
| Founded | 1906 | 1999 |
| Country | United States | United States |
| Employees | 22900 | 1100 |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.6M | 419.3M |
| IPO Year | 2019 | 2008 |
| Metric | XRX | CYRX |
|---|---|---|
| Price | $2.78 | $13.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $2.50 | ★ $13.31 |
| AVG Volume (30 Days) | ★ 7.7M | 556.3K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 6.31% | N/A |
| EPS Growth | 23.26 | ★ 156.22 |
| EPS | N/A | ★ N/A |
| Revenue | $117,000,000.00 | ★ $176,177,000.00 |
| Revenue This Year | $8.96 | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.19 | $5.31 |
| 52 Week High | $6.80 | $13.28 |
| Indicator | XRX | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 72.35 | 81.62 |
| Support Level | $2.33 | $7.98 |
| Resistance Level | $2.89 | N/A |
| Average True Range (ATR) | 0.27 | 0.65 |
| MACD | 0.10 | 0.29 |
| Stochastic Oscillator | 77.44 | 99.75 |
Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.